ANI Pharmaceuticals Inc (NASDAQ:ANIP)
| 26.51 Delayed Data As of May 13 |  +1.50 / +6.00%Today’s Change | 22.73 Today|||52-Week Range 60.23 | -42.47% Year-to-Date |
Latest ANIP News | Press Releases
| Top 5 1st Quarter Trades of Walthausen & Co., LLC May 11 / GuruFocus News - Paid Partner Content | Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates May 09 / Zacks.com - Paid Partner Content |
| ANI Pharmaceuticals (ANIP) Reports Q1 Loss, Misses Revenue Estimates May 10 / Zacks.com - Paid Partner Content | Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates May 05 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 25.01 |
| Today’s open | 26.03 |
| Day’s range | 24.45 - 26.61 |
| Volume | 3,883 |
| Average volume (3 months) | 126,653 |
| Market cap | $446.4M |
Data as of 4:00pm ET, 05/13/2022
Growth & Valuation
| Earnings growth (last year) | -80.27% |
| Earnings growth (this year) | -57.01% |
| Earnings growth (next 5 years) | +17.70% |
| Revenue growth (last year) | +3.67% |
| P/E ratio | NM |
| Price/Sales | 2.69 |
| Price/Book | 1.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OCGNOcugen Inc | +0.19 | +9.69% |
| CARACara Therapeutics In... | +0.79 | +10.38% |
| BNGOBionano Genomics Inc | +0.21 | +14.54% |
| AGENAgenus Inc | +0.08 | +5.48% |
Data as of 4:29pm ET, 05/13/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | $0.24 |
| Annual revenue (last year) | $216.1M |
| Annual profit (last year) | -$42.6M |
| Net profit margin | -19.71% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Baudette, Minnesota |
Forecasts
